A prospective study of the prognostic value of cathepsin D levels in breast cancer cytosol

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Cancer

• Publication date

  1993-03-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/1097-0142(19930315)71:6<2006::AID-CNCR2820710614>3.0.CO;2-QPMID 8443752
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Presurgical radiotherapy decreases the concentrations of estrogen and progesterone receptors in human breast cancer: A 200-patient study

  2005cited by this paper
• Cathepsin D in breast cancer: a tissue marker associated with metastasis.

  1992cited by this paper
• Prognostic value of total cathepsin D in breast tumors

  1991cited by this paper
• Prognostic relevance of cathepsin D versus oestrogen receptors in node negative breast cancers.

  1991cited by this paper
• Cathepsin D and prognosis in breast cancer.

  1990cited by this paper
• Cathepsin D in breast cancer

  1990cited by this paper
• Overexpression of transfected cathepsin D in transformed cells increases their malignant phenotype and metastatic potency.

  1990cited by this paper
• Adjuvant therapy for node-negative breast cancer.

  1989cited by this paper
• The Lancet: saturday 11 November 1989

  1989cited by this paper
• Cathepsin D: an independent prognostic factor for metastasis of breast cancer.

  1989cited by this paper
• Association between high concentrations of Mr 52,000 cathepsin D and poor prognosis in primary human breast cancer.

  1989cited by this paper
• Adjuvant therapy in node-negative breast cancer

  1989cited by this paper
• Two-site immunoenzymometric assay for the 52-kDa cathepsin D in cytosols of breast cancer tissues.

  1989cited by this paper
• Immunoenzymatic assay of Mr 52,000 cathepsin D in 182 breast cancer cytosols: low correlation with other prognostic parameters.

  1988cited by this paper
• In vitro degradation of extracellular matrix with Mr 52,000 cathepsin D secreted by breast cancer cells.

  1988cited by this paper
• Characterization of monoclonal antibodies to the estrogen-regulated Mr 52,000 glycoprotein and their use in MCF7 cells.

  1985cited by this paper
• Release of estrogen-induced glycoprotein with a molecular weight of 52,000 by breast cancer cells in primary culture.

  1983cited by this paper
• BMDP statistical software

  1983cited by this paper
• Regression models and life tables (with discussion

  1972cited by this paper
• Cancer of the breast: Size of neoplasm and prognosis

  1969cited by this paper
• Histological Grading and Prognosis in Breast Cancer

  1957cited by this paper

• Prognostic role of high cathepsin D expression in breast cancer: a systematic review and meta-analysis

  2020cites this paper
• The Role of Cathepsins in the Growth of Primary and Secondary Neoplasia in the Bone

  2020cites this paper
• Significance of the tumor protease cathepsin D for the biology of breast cancer.

  2014cites this paper
• Detection of oral squamous cell carcinoma metastasis with cathepsin D: An immunohistochemical approach

  2014cites this paper
• New insights into procathepsin D in pathological and physiological conditions

  2011cites this paper
• Reevaluating Cathepsin D as a biomarker for breast cancer: Serum activity levels versus histopathology

  2010cites this paper
• Nitration of cathepsin D enhances its proteolytic activity during mammary gland remodelling after lactation.

  2009cites this paper
• THE CLINICAL SIGNIFICANCE OF LYMPH-NODE METASTASIS

  2009cites this paper
• Possible role of procathepsin D in human cancer

  2008cites this paper
• The relative prognostic significance of total cathepsin D and HER‐2/neu oncogene amplification in breast cancer

  2007cites this paper
• Activity of cathepsin D and alpha(1)-antitrypsin in the blood serum of patients with mammary carcinoma.

  2005cites this paper
• Prognostic and predictive value of cathepsins D and L in operable breast cancer patients.

  2005cites this paper
• Immunohistochemical detection of nm23/NDP kinase and cathepsin D in medullary carcinomas of the thyroid gland

  2004cites this paper
• Reply

  2004cites this paper
• The relationship between prognostic and predictive factors in the management of breast cancer

  2004cites this paper
• Response to P.M. Ravdin (BCRT 24:219-226, 1993), “Evaluation of cathepsin D as a prognostic factor in breast cancer”

  2004cites this paper
• Prognostic evaluation of oestrogen-regulated protein immunoreactivity in ductal invasive (NOS) breast cancer

  2004cites this paper
• Prognostic factors in prostate cancer.

  2003cites this paper
• Molecular and genetic prognostic factors of prostate cancer

  2003cites this paper
• Keeping Data Continuous when Analyzing the Prognostic Impact of a Tumor Marker: An Example with Cathepsin D in Breast Cancer

  2003cites this paper
• Giant-cell tumors of bone and progesterone receptors.

  2003cites this paper
• Immunoradiometric assay of cathepsin D: Estrogen regulated vs. non estrogen- regulated cathepsin D expression in relation to clinicopathological features of breast cancer

  2002cites this paper
• Prognostic markers inprostate cancer

  2002cites this paper
• Procathepsin D in breast cancer: What do we know? Effects of ribozymes and other inhibitors

  2002cites this paper
• Morphologic and Molecular Prognostic Markers in Prostate Cancer

  2002cites this paper
• Immunohistochemical cathepsin-D expression in breast cancer: correlation with established pathological parameters and survival.

  2001cites this paper
• A comparison of the patterns of laminin expression in fibroadenoma, fibrocystic diseases, pre-invasive and invasive ductal breast carcinoma.

  2001cites this paper
• Prognostic impact of cathepsin D and c-erbB-2 oncoprotein in a subgroup of node-negative breast cancer patients with low histological grade tumors.

  2001cites this paper
• Predictive value of cathepsin D and Ki-67 expression at the deepest penetration site for lymph node metastases in gastric cancer.

  2000cites this paper
• Time at surgery during menstrual cycle and menopause affects pS2 but not cathepsin D levels in breast cancer

  1999cites this paper
• Prognostic value of ornithine decarboxylase and polyamines in human breast cancer: correlation with clinicopathologic parameters.

  1999cites this paper
• Apport de la biologie tissulaire à la décision thérapeutique dans le cancer du sein

  1999cites this paper
• Ddsurjqrvwlffvwxg\\riiphwdvwdvlvvdqggorfdoouhfxuuhqfh 7llqdd-dknrod 8qlyhuvlw\rii+hovlqnl)lqodqg )rxuwk'hsduwphqwri6xujhu\dqg 'hsduwphqwri2qfrorj\ $fdghplf'lvvhuwdwlrq +hovlqnll

  1999cites this paper
• Cathepsin-D, urokinase plasminogen activator and type-1 plasminogen activator inhibitor in early breast cancer: an immunohistochemical study of prognostic value and relations to tenascin-C and other factors

  1999cites this paper
• Predictive value of c-erbB-2 and cathepsin-D for Greek breast cancer patients using univariate and multivariate analysis.

  1999cites this paper
• A COMPARISON OF THE PATTERN OF CATHEPSIN-D EXPRESSION IN FIBROADENOMA, FIBROCYSTIC DISEASE, PREINVASIVE AND INVASIVE DUCTAL BREAST CARCINOMA

  1999cites this paper
• A comparison of the pattern of cathepsin-D expression in fibroadenoma, fibrocystic disease, preinvasive and invasive ductal breast carcinoma.

  1999cites this paper
• Gsα, protein kinase C, cathepsin D, growth factors, estrogen receptor-related protein, and p53 in prolactin cell adenomas and null cell adenomas of the pituitary

  1998cites this paper
• Immunohistochemical Quantification and Determination of Cathepsin D in Prostatic Neoplasia: Correlation with Steroid Receptors

  1998cites this paper
• Cytosol concentrations of CD44 isoforms in breast cancer tissue

  1998cites this paper
• Axillary lymph node dissection for breast cancer: A decision analysis of T1 lesions

  1998cites this paper
• Prognostic relevance of cathepsin D detection in micrometastatic cells in the bone marrow of patients with primary breast cancer

  1998cites this paper
• [Prognostic factors in breast cancer with contralateral supraclavicular or axillary lymphatic metastases].

  1998cites this paper
• Evaluation of cathepsin D immunostaining in colorectal adenocarcinoma

  1997cites this paper
• Medullary Carcinoma of the Breast

  1997cites this paper
• Western immunoblotting and enzymatic activity analysis of cathepsin D in human breast cancer cell lines of different invasive potential. Regulation by 17β-estradiol, tamoxifen and ICI 182,780

  1997cites this paper
• Breast cancer metastasis-associated genes: prognostic significance and therapeutic implications.

  1997cites this paper
• Relationship between cathepsin-D content and disease-free survival in node-negative breast cancer patients: a meta-analysis.

  1997influential citation
• Mechanism of growth inhibition by calpain inhibitor in MCF-7 cells.

  1997cites this paper
• Correlation of two methods for determination of cathepsin D in breast carcinoma (immunohistochemistry and ELISA in cytosol)

  1997cites this paper
• Relationship between Cathepsin-D and Other Prognostic Factors in Human Breast Cancer

  1997cites this paper
• Immunohistochemical evaluation of cathepsin D expression in colorectal cancer.

  1997cites this paper
• Tumor‐related prognostic factors for breast cancer

  1997cites this paper
• Lack of prognostic value of cathepsin D levels for predicting short term outcomes of breast cancer patients.

  1997cites this paper
• Influence of cathepsin D expression in lung adenocarcinoma on prognosis: Possible importance of its expression in tumor cells and stromal cells, and its intracellular polarization in tumor cells

  1997cites this paper
• Prognostic Factors in Breast Cancer

  1997cites this paper
• Relationship betweencathepsin-D contentand disease-free survival innode-negative breastcancer patients: ameta-analysis

  1997cites this paper
• Western immunoblotting and enzymatic activity analysis of cathepsin D in human breast cancer cell lines of different invasive potential. Regulation by 17beta-estradiol, tamoxifen and ICI 182,780.

  1997cites this paper
• Immunohistochemical p53 overexpression correlated to c-erbB-2 and cathepsin D proteins in colorectal cancer.

  1996cites this paper
• Cathepsin D versus Other Prognostic Factors in Breast Cancer. Results and Controversies of a Multicenter Study on 2575 Cases

  1996influential citation
• Prognostic value of cathepsin D in breast cancer: comparison of immunohistochemical and immunoradiometric detection methods.

  1996cites this paper
• Specific oncological contribution of cathepsin D and pS2 in human breast cancer: their relationship with TNM status, estradiol receptors, epidermal growth factor receptor and neu amplification.

  1996cites this paper
• Cathepsins D and B in breast cancer.

  1996cites this paper
• The immunohistochemical expression of cathepsin D in colorectal cancer.

  1996cites this paper
• Critical evaluation of prognostic factors.

  1996cites this paper
• Node negative breast carcinoma: Hyperprolactinemia and/or overexpression of p53 as an independent predictor of poor prognosis compared to newer and established prognosticators

  1996cites this paper
• Cathepsin D and breast cancer.

  1996cites this paper
• Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. Adopted on May 17, 1996 by the American Society of Clinical Oncology.

  1996cites this paper
• Evaluation of the prognostic significance of nm23/NDP kinase and cathepsin D in anal carcinomas

  1996cites this paper
• Proteases as prognostic markers in cancer.

  1996cites this paper
• Pathological and biological features of mammographically detected invasive breast carcinomas.

  1995cites this paper
• Assay of matrix metalloproteases types 8 and 9 by ELISA in human breast cancer.

  1995cites this paper
• Elevated levels of pro-cathepsin-d in the plasma of breast-cancer patients.

  1995cites this paper
• [Contribution of biology to the therapeutic decision: cancer of the breast in 1995].

  1995cites this paper
• Apport de la biologie à la décision thérapeutique: le cancer du sein en 1995

  1995cites this paper
• Significance of estrogen receptors and cathepsin D tissue detection in gastric adenocarcinoma

  1995cites this paper
• Quantitative immunohistochemical determination of cathepsin D levels in prostatic carcinoma biopsies. Correlation with tumor grade, stage, PSA level, and DNA ploidy status.

  1995cites this paper
• Relationship between cathepsin D and other pathological and biological parameters in 1752 patients with primary breast cancer.

  1995cites this paper
• Stromal cell cathepsin D expression and long-term survival in breast cancer.

  1995cites this paper
• Endometrial adenocarcinoma of endometrioid subtype with squamous differentiation: an immunohistochemical study of MIB-1 (ki-67 paraffin), cathepsin D, and C-erbB-2 protein (p185).

  1995cites this paper
• Cathepsin D, both a prognostic factor and a predictive factor for the effect of adjuvant tamoxifen in breast cancer. South Sweden Breast Cancer Group.

  1994cites this paper
• Cathepsin D by western blotting and immunohistochemistry: failure to confirm correlations with prognosis in node-negative breast cancer.

  1994cites this paper
• Immunohistochemical expression of ps2 and cathepsin-d in breast-cancer - relationship with er, pgr immunostainings and clinicopathological aspects.

  1994cites this paper
• Comparative quantitative immunohistochemical and immunoradiometric determinations of cathepsin D in endometrial adenocarcinoma: predictors of tumor aggressiveness.

  1994cites this paper
• Immunohistochemical analysis of cathepsins D, B, and L in human breast cancer.

  1994cites this paper
• Prognostic indicators for early-stage breast-carcinoma .2. Value of cathepsin-d expression, detected by immunocytochemistry - a multiparametric study.

  1994cites this paper
• Cathepsin D immunostaining in paraffin-embedded breast cancer cells and macrophages: correlation with cytosolic assay.

  1994cites this paper
• Prognostic factors in early breast carcinoma

  1994cites this paper
• The m1g8 monoclonal-antibody - a comparison between paraffin-embedded and frozen-sections from breast-cancer.

  1994cites this paper
• Analysis of breast-tissue cathepsin-d isoforms from patients with breast-cancer, benign breast disease and from normal controls.

  1994cites this paper
• Male breast cancer.

  1994cites this paper
• Immunohistochemical Detection of Cathepsin D in T2N0M0 Breast Carcinoma

  1994cites this paper
• Urokinase plasminogen activator as a prognostic marker in different subgroups of patients with breast cancer

  1994cites this paper
• Cathepsin-d in breast carcinomas - the role of the stromal cell component.

  1994cites this paper
• Response to P.M. Ravdin (BCRT 24:219-226, 1993), “Evaluation of cathepsin D as a prognostic factor in breast cancer”

  1993cites this paper
• Biological Factors and Treatment Decision in Early Breast Cancer

  1993cites this paper
• Evaluation of cathepsin D as a prognostic factor in breast cancer

  1993cites this paper